Jane Street Group, LLC Mereo Biopharma Group PLC Transaction History
Jane Street Group, LLC
- $445 Billion
- Q3 2024
A detailed history of Jane Street Group, LLC transactions in Mereo Biopharma Group PLC stock. As of the latest transaction made, Jane Street Group, LLC holds 214,635 shares of MREO stock, worth $768,393. This represents 0.0% of its overall portfolio holdings.
Number of Shares
214,635
Previous 84,593
153.73%
Holding current value
$768,393
Previous $304,000
190.13%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding MREO
# of Institutions
84Shares Held
107MCall Options Held
209KPut Options Held
479K-
Rubric Capital Management LP New York, NY15.3MShares$54.8 Million1.75% of portfolio
-
Janus Henderson Group PLC London, X012.3MShares$44.2 Million0.03% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA9.72MShares$34.8 Million0.07% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD9.53MShares$34.1 Million1.33% of portfolio
-
Mangrove Partners New York, NY8.73MShares$31.3 Million4.66% of portfolio
About Mereo Biopharma Group plc
- Ticker MREO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 124,986,000
- Market Cap $447M
- Description
- Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom and internationally. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the tr...